Tumor-specific isoform switch of the fibroblast growth factor receptor 2 underlies the mesenchymal and malignant phenotypes of clear cell renal cell carcinomas

Qi Zhao; Otavia Caballero; Ian Davis; Eric Jonasch; Pheroze Tamboli; W K Alfred Yung; John N Weinstein; Kenna Shaw; Robert L Strausberg; Jun Yao

doi:10.1158/1078-0432.CCR-12-3708

Tumor-specific isoform switch of the fibroblast growth factor receptor 2 underlies the mesenchymal and malignant phenotypes of clear cell renal cell carcinomas

Qi Zhao, Otavia Caballero, Ian Davis, Eric Jonasch, Pheroze Tamboli, W K Alfred Yung, John N Weinstein, Kenna Shaw, Robert L Strausberg, Jun Yao

Eastern Health Clinical School

Research output: Contribution to journal › Article › Research › peer-review

72 Citations (Scopus)

Original language	English
Pages (from-to)	2460 - 2472
Number of pages	13
Journal	Clinical Cancer Research
Volume	19
Issue number	9
DOIs	https://doi.org/10.1158/1078-0432.CCR-12-3708
Publication status	Published - 2013

Access to Document

10.1158/1078-0432.CCR-12-3708

Cite this

Zhao, Q., Caballero, O., Davis, I., Jonasch, E., Tamboli, P., Yung, W. K. A., Weinstein, J. N., Shaw, K., Strausberg, R. L., & Yao, J. (2013). Tumor-specific isoform switch of the fibroblast growth factor receptor 2 underlies the mesenchymal and malignant phenotypes of clear cell renal cell carcinomas. Clinical Cancer Research, 19(9), 2460 - 2472. https://doi.org/10.1158/1078-0432.CCR-12-3708

@article{33ab66b3be4f482ba2bd86aafacf0989,

title = "Tumor-specific isoform switch of the fibroblast growth factor receptor 2 underlies the mesenchymal and malignant phenotypes of clear cell renal cell carcinomas",

author = "Qi Zhao and Otavia Caballero and Ian Davis and Eric Jonasch and Pheroze Tamboli and Yung, {W K Alfred} and Weinstein, {John N} and Kenna Shaw and Strausberg, {Robert L} and Jun Yao",

year = "2013",

doi = "10.1158/1078-0432.CCR-12-3708",

language = "English",

volume = "19",

pages = "2460 -- 2472",

journal = "Clinical Cancer Research",

issn = "1078-0432",

publisher = "American Association for Cancer Research (AACR)",

number = "9",

}

Zhao, Q, Caballero, O, Davis, I, Jonasch, E, Tamboli, P, Yung, WKA, Weinstein, JN, Shaw, K, Strausberg, RL & Yao, J 2013, 'Tumor-specific isoform switch of the fibroblast growth factor receptor 2 underlies the mesenchymal and malignant phenotypes of clear cell renal cell carcinomas', Clinical Cancer Research, vol. 19, no. 9, pp. 2460 - 2472. https://doi.org/10.1158/1078-0432.CCR-12-3708

TY - JOUR

T1 - Tumor-specific isoform switch of the fibroblast growth factor receptor 2 underlies the mesenchymal and malignant phenotypes of clear cell renal cell carcinomas

AU - Zhao, Qi

AU - Caballero, Otavia

AU - Davis, Ian

AU - Jonasch, Eric

AU - Tamboli, Pheroze

AU - Yung, W K Alfred

AU - Weinstein, John N

AU - Shaw, Kenna

AU - Strausberg, Robert L

AU - Yao, Jun

PY - 2013

Y1 - 2013

UR - http://clincancerres.aacrjournals.org/content/19/9/2460.full.pdf

U2 - 10.1158/1078-0432.CCR-12-3708

DO - 10.1158/1078-0432.CCR-12-3708

M3 - Article

SN - 1078-0432

VL - 19

SP - 2460

EP - 2472

JO - Clinical Cancer Research

JF - Clinical Cancer Research

IS - 9

ER -

Tumor-specific isoform switch of the fibroblast growth factor receptor 2 underlies the mesenchymal and malignant phenotypes of clear cell renal cell carcinomas

Access to Document

Other files and links

Cite this